APA

Eron J. J., Johnson V. A., Merrill D. P., Chou T. C. & Hirsch M. S. (19920922). Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. : Antimicrobial agents and chemotherapy.

Chicago

Eron J J, Johnson V A, Merrill D P, Chou T C and Hirsch M S. 19920922. Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. : Antimicrobial agents and chemotherapy.

Harvard

Eron J. J., Johnson V. A., Merrill D. P., Chou T. C. and Hirsch M. S. (19920922). Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. : Antimicrobial agents and chemotherapy.

MLA

Eron J J, Johnson V A, Merrill D P, Chou T C and Hirsch M S. Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. : Antimicrobial agents and chemotherapy. 19920922.